Global Health Status Monitoring Market

Health Status Monitoring Comprehensive Study by Type (Blood Glucose Monitoring Systems, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Temperature Monitoring Devices, Others), Category (Device, Wearable, Others), End Use (Hospitals, Ambulatory Surgery Centers, Home Care Settings) Players and Region - Global Market Outlook to 2030

Health Status Monitoring Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
Health professionals and doctors are utilising cutting-edge technology to effect significant change in medical services in clinical settings. Patient monitoring system is a system used to monitor physiological indicators such as the electrocardiogram (ECG), respiratory signs, intrusive and noninvasive blood pressure, body temperature, gas related parameters, and so on. Health Monitoring System (HMS) is a sophisticated technology that provides an alternative to traditional patient and health management. It comprises of a wireless wearable device, similar to a bracelet, with sensors that are linked to an application that allows a doctor to obtain medical data. With the fast rise of the older population, there is an urgent need to assist elders' capacity to retain an independent and healthy lifestyle in their homes rather than in more expensive and secluded care facilities. One way to achieving these goals is to use ambient intelligence ideas to remotely monitor an elder's activities and condition. Also, Stay up-to-date with latest research insights on "Smart Home Healthcare Market Share & Industry Growth Analysis".

Highlights from Health Status Monitoring Market Study
AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The key Players profiled in the report are Abbott Laboratories (United States), Drägerwerk AG & Co. KGaA (Germany), Hill-Rom Holdings, Inc. (United States), Natus Medical (United States), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (United States), Getinge AB (Sweden), Boston Scientific Corporation (United States) and BioTelemetry, Inc. (United States). Additionally, other players that are part of this comprehensive study are Edwards Lifesciences Corporation (United States), OMRON Corporation (Japan), Masimo Corporation (United States), Compumedics Limited (Australia), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) and Nihon Kohden Corporation (Japan).

Geographic Breakdown and Segment Analysis
The Global Health Status Monitoring market presents a comprehensive analysis of the Health Status Monitoring market by product type (Blood Glucose Monitoring Systems, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Temperature Monitoring Devices and Others), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Health Status Monitoring industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Health Status Monitoring market

Analyst at AMA have segmented the market study of Global Health Status Monitoring market by Type, Application and Region.

Influencing Trend:
Rising Preference for Wearable Patient Monitoring Devices, Biosensors, And Smart Implants

Market Growth Drivers:
Technical Progress in Patient Monitoring Systems and Prevalence of Chronic Diseases & Infections

Challenges:
Lack of Skilled Professionals and High initial Investment

Restraints:
Hugh Cost Expenditure

Opportunities:
High Investment in Healthcare R&D and Growing Demand for Patient Monitoring Devices in Non-Hospital Settings

Market Developments Activities:
In February 2021 ,Philips Completed its Acquisition of Biotelemetry, Inc. (Leading Remote Cardiac Diagnostics and Monitoring Solutions Provider). The Purchase of BioTelemetry Aligns Well with Philips' Cardiac Care Portfolio and Its Aim to Change Care Delivery Across the Health Continuum with Integrated Solutions. and On 5th August 2021 - ModivCare Acquired Remote Patient Monitoring Company VRI Intermediate. The Acquisition Adds a Critical Supportive Care Platform with Unique Data Analytics to Benefit Payors and Patients. The Combination is Aimed to Advance Supportive Care and Help Drive Value-Based Care Solutions.
In March, 2020 , Medtronic Launched New Solutions to Help Monitor Patients for COVID-19. The Respiratory Infectious Disease Health Check Assists Individuals with Chronic, Co-Morbid Health Problems Who Are at The Highest Risk For COVID-19 Complications or Fatality by Tracking Respiratory Infectious Disease Symptoms.



The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Key Target Audience
Health Status Monitoring Solution Providers, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Blood Glucose Monitoring Systems
  • Cardiac Monitoring Devices
  • Respiratory Monitoring Devices
  • Temperature Monitoring Devices
  • Others
By Category
  • Device
  • Wearable
  • Others

By End Use
  • Hospitals
  • Ambulatory Surgery Centers
  • Home Care Settings

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Technical Progress in Patient Monitoring Systems
      • 3.2.2. Prevalence of Chronic Diseases & Infections
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
      • 3.3.2. High initial Investment
    • 3.4. Market Trends
      • 3.4.1. Rising Preference for Wearable Patient Monitoring Devices, Biosensors, And Smart Implants
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Health Status Monitoring, by Type, Category, End Use and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Health Status Monitoring (Value)
      • 5.2.1. Global Health Status Monitoring by: Type (Value)
        • 5.2.1.1. Blood Glucose Monitoring Systems
        • 5.2.1.2. Cardiac Monitoring Devices
        • 5.2.1.3. Respiratory Monitoring Devices
        • 5.2.1.4. Temperature Monitoring Devices
        • 5.2.1.5. Others
      • 5.2.2. Global Health Status Monitoring by: Category (Value)
        • 5.2.2.1. Device
        • 5.2.2.2. Wearable
        • 5.2.2.3. Others
      • 5.2.3. Global Health Status Monitoring by: End Use (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgery Centers
        • 5.2.3.3. Home Care Settings
      • 5.2.4. Global Health Status Monitoring Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Health Status Monitoring: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Drägerwerk AG & Co. KGaA (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hill-Rom Holdings, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Natus Medical (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medtronic plc (Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Koninklijke Philips N.V. (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GE Healthcare (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Getinge AB (Sweden)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Boston Scientific Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. BioTelemetry, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Health Status Monitoring Sale, by Type, Category, End Use and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Health Status Monitoring (Value)
      • 7.2.1. Global Health Status Monitoring by: Type (Value)
        • 7.2.1.1. Blood Glucose Monitoring Systems
        • 7.2.1.2. Cardiac Monitoring Devices
        • 7.2.1.3. Respiratory Monitoring Devices
        • 7.2.1.4. Temperature Monitoring Devices
        • 7.2.1.5. Others
      • 7.2.2. Global Health Status Monitoring by: Category (Value)
        • 7.2.2.1. Device
        • 7.2.2.2. Wearable
        • 7.2.2.3. Others
      • 7.2.3. Global Health Status Monitoring by: End Use (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgery Centers
        • 7.2.3.3. Home Care Settings
      • 7.2.4. Global Health Status Monitoring Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Health Status Monitoring: by Type(USD Million)
  • Table 2. Health Status Monitoring Blood Glucose Monitoring Systems , by Region USD Million (2018-2023)
  • Table 3. Health Status Monitoring Cardiac Monitoring Devices , by Region USD Million (2018-2023)
  • Table 4. Health Status Monitoring Respiratory Monitoring Devices , by Region USD Million (2018-2023)
  • Table 5. Health Status Monitoring Temperature Monitoring Devices , by Region USD Million (2018-2023)
  • Table 6. Health Status Monitoring Others , by Region USD Million (2018-2023)
  • Table 7. Health Status Monitoring: by Category(USD Million)
  • Table 8. Health Status Monitoring Device , by Region USD Million (2018-2023)
  • Table 9. Health Status Monitoring Wearable , by Region USD Million (2018-2023)
  • Table 10. Health Status Monitoring Others , by Region USD Million (2018-2023)
  • Table 11. Health Status Monitoring: by End Use(USD Million)
  • Table 12. Health Status Monitoring Hospitals , by Region USD Million (2018-2023)
  • Table 13. Health Status Monitoring Ambulatory Surgery Centers , by Region USD Million (2018-2023)
  • Table 14. Health Status Monitoring Home Care Settings , by Region USD Million (2018-2023)
  • Table 15. South America Health Status Monitoring, by Country USD Million (2018-2023)
  • Table 16. South America Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 17. South America Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 18. South America Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 19. Brazil Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 20. Brazil Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 21. Brazil Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 22. Argentina Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 23. Argentina Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 24. Argentina Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 25. Rest of South America Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 26. Rest of South America Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 27. Rest of South America Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 28. Asia Pacific Health Status Monitoring, by Country USD Million (2018-2023)
  • Table 29. Asia Pacific Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 30. Asia Pacific Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 31. Asia Pacific Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 32. China Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 33. China Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 34. China Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 35. Japan Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 36. Japan Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 37. Japan Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 38. India Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 39. India Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 40. India Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 41. South Korea Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 42. South Korea Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 43. South Korea Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 44. Taiwan Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 45. Taiwan Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 46. Taiwan Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 47. Australia Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 48. Australia Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 49. Australia Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 53. Europe Health Status Monitoring, by Country USD Million (2018-2023)
  • Table 54. Europe Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 55. Europe Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 56. Europe Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 57. Germany Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 58. Germany Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 59. Germany Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 60. France Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 61. France Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 62. France Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 63. Italy Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 64. Italy Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 65. Italy Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 66. United Kingdom Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 67. United Kingdom Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 68. United Kingdom Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 69. Netherlands Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 70. Netherlands Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 71. Netherlands Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 72. Rest of Europe Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 73. Rest of Europe Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 74. Rest of Europe Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 75. MEA Health Status Monitoring, by Country USD Million (2018-2023)
  • Table 76. MEA Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 77. MEA Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 78. MEA Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 79. Middle East Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 80. Middle East Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 81. Middle East Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 82. Africa Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 83. Africa Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 84. Africa Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 85. North America Health Status Monitoring, by Country USD Million (2018-2023)
  • Table 86. North America Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 87. North America Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 88. North America Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 89. United States Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 90. United States Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 91. United States Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 92. Canada Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 93. Canada Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 94. Canada Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 95. Mexico Health Status Monitoring, by Type USD Million (2018-2023)
  • Table 96. Mexico Health Status Monitoring, by Category USD Million (2018-2023)
  • Table 97. Mexico Health Status Monitoring, by End Use USD Million (2018-2023)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Health Status Monitoring: by Type(USD Million)
  • Table 109. Health Status Monitoring Blood Glucose Monitoring Systems , by Region USD Million (2025-2030)
  • Table 110. Health Status Monitoring Cardiac Monitoring Devices , by Region USD Million (2025-2030)
  • Table 111. Health Status Monitoring Respiratory Monitoring Devices , by Region USD Million (2025-2030)
  • Table 112. Health Status Monitoring Temperature Monitoring Devices , by Region USD Million (2025-2030)
  • Table 113. Health Status Monitoring Others , by Region USD Million (2025-2030)
  • Table 114. Health Status Monitoring: by Category(USD Million)
  • Table 115. Health Status Monitoring Device , by Region USD Million (2025-2030)
  • Table 116. Health Status Monitoring Wearable , by Region USD Million (2025-2030)
  • Table 117. Health Status Monitoring Others , by Region USD Million (2025-2030)
  • Table 118. Health Status Monitoring: by End Use(USD Million)
  • Table 119. Health Status Monitoring Hospitals , by Region USD Million (2025-2030)
  • Table 120. Health Status Monitoring Ambulatory Surgery Centers , by Region USD Million (2025-2030)
  • Table 121. Health Status Monitoring Home Care Settings , by Region USD Million (2025-2030)
  • Table 122. South America Health Status Monitoring, by Country USD Million (2025-2030)
  • Table 123. South America Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 124. South America Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 125. South America Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 126. Brazil Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 127. Brazil Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 128. Brazil Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 129. Argentina Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 130. Argentina Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 131. Argentina Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 132. Rest of South America Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 133. Rest of South America Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 134. Rest of South America Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 135. Asia Pacific Health Status Monitoring, by Country USD Million (2025-2030)
  • Table 136. Asia Pacific Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 137. Asia Pacific Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 138. Asia Pacific Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 139. China Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 140. China Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 141. China Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 142. Japan Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 143. Japan Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 144. Japan Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 145. India Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 146. India Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 147. India Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 148. South Korea Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 149. South Korea Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 150. South Korea Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 151. Taiwan Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 152. Taiwan Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 153. Taiwan Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 154. Australia Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 155. Australia Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 156. Australia Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 158. Rest of Asia-Pacific Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 159. Rest of Asia-Pacific Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 160. Europe Health Status Monitoring, by Country USD Million (2025-2030)
  • Table 161. Europe Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 162. Europe Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 163. Europe Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 164. Germany Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 165. Germany Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 166. Germany Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 167. France Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 168. France Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 169. France Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 170. Italy Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 171. Italy Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 172. Italy Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 173. United Kingdom Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 174. United Kingdom Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 175. United Kingdom Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 176. Netherlands Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 177. Netherlands Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 178. Netherlands Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 179. Rest of Europe Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 180. Rest of Europe Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 181. Rest of Europe Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 182. MEA Health Status Monitoring, by Country USD Million (2025-2030)
  • Table 183. MEA Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 184. MEA Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 185. MEA Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 186. Middle East Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 187. Middle East Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 188. Middle East Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 189. Africa Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 190. Africa Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 191. Africa Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 192. North America Health Status Monitoring, by Country USD Million (2025-2030)
  • Table 193. North America Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 194. North America Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 195. North America Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 196. United States Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 197. United States Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 198. United States Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 199. Canada Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 200. Canada Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 201. Canada Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 202. Mexico Health Status Monitoring, by Type USD Million (2025-2030)
  • Table 203. Mexico Health Status Monitoring, by Category USD Million (2025-2030)
  • Table 204. Mexico Health Status Monitoring, by End Use USD Million (2025-2030)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Health Status Monitoring: by Type USD Million (2018-2023)
  • Figure 5. Global Health Status Monitoring: by Category USD Million (2018-2023)
  • Figure 6. Global Health Status Monitoring: by End Use USD Million (2018-2023)
  • Figure 7. South America Health Status Monitoring Share (%), by Country
  • Figure 8. Asia Pacific Health Status Monitoring Share (%), by Country
  • Figure 9. Europe Health Status Monitoring Share (%), by Country
  • Figure 10. MEA Health Status Monitoring Share (%), by Country
  • Figure 11. North America Health Status Monitoring Share (%), by Country
  • Figure 12. Global Health Status Monitoring share by Players 2023 (%)
  • Figure 13. Global Health Status Monitoring share by Players (Top 3) 2023(%)
  • Figure 14. Global Health Status Monitoring share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 17. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 18. Drägerwerk AG & Co. KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Drägerwerk AG & Co. KGaA (Germany) Revenue: by Geography 2023
  • Figure 20. Hill-Rom Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Hill-Rom Holdings, Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Natus Medical (United States) Revenue, Net Income and Gross profit
  • Figure 23. Natus Medical (United States) Revenue: by Geography 2023
  • Figure 24. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 25. Medtronic plc (Ireland) Revenue: by Geography 2023
  • Figure 26. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 27. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2023
  • Figure 28. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 29. GE Healthcare (United States) Revenue: by Geography 2023
  • Figure 30. Getinge AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 31. Getinge AB (Sweden) Revenue: by Geography 2023
  • Figure 32. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 34. BioTelemetry, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. BioTelemetry, Inc. (United States) Revenue: by Geography 2023
  • Figure 36. Global Health Status Monitoring: by Type USD Million (2025-2030)
  • Figure 37. Global Health Status Monitoring: by Category USD Million (2025-2030)
  • Figure 38. Global Health Status Monitoring: by End Use USD Million (2025-2030)
  • Figure 39. South America Health Status Monitoring Share (%), by Country
  • Figure 40. Asia Pacific Health Status Monitoring Share (%), by Country
  • Figure 41. Europe Health Status Monitoring Share (%), by Country
  • Figure 42. MEA Health Status Monitoring Share (%), by Country
  • Figure 43. North America Health Status Monitoring Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Drägerwerk AG & Co. KGaA (Germany)
  • Hill-Rom Holdings, Inc. (United States)
  • Natus Medical (United States)
  • Medtronic plc (Ireland)
  • Koninklijke Philips N.V. (Netherlands)
  • GE Healthcare (United States)
  • Getinge AB (Sweden)
  • Boston Scientific Corporation (United States)
  • BioTelemetry, Inc. (United States)
Additional players considered in the study are as follows:
Edwards Lifesciences Corporation (United States) , OMRON Corporation (Japan) , Masimo Corporation (United States) , Compumedics Limited (Australia) , Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) , Nihon Kohden Corporation (Japan)
Select User Access Type

Key Highlights of Report


Apr 2024 189 Pages 76 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Health Status Monitoring Market Quantitative research analysis
Global Health Status Monitoring Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2030
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
  • Lack of Skilled Professionals
  • High initial Investment

Know More About Global Health Status Monitoring Market Report?

Have a Query? Click Here

Other Related Reports

Artificial Intelligence In Remote Patient Monitoring Comprehensive Study by Type (Wireless, Portable, Real-time, Continuous), Application (Wearable heart monitors, Bluetooth-enabled scales, Glucose m...
$ 3650
Nucleic Acid Electrophoresis Comprehensive Study by Application (Research, Diagnostics), End Users (Research Institutes, Hospitals, Diagnostics Centre), Instrument (Horizontal Gel Electrophoresis Sys...
$ 3450
Augmented Intelligence in Healthcare Comprehensive Study by Application (Care Coordination Command Center, Mental Health Tracking, Population Health Management, Research & Drug Discovery, Precision M...
$ 3750
Clinical Software Comprehensive Study by Application (Hospitals, Clinics, Medical Research Centres, Others), End-Use Industries (Pharmaceutical, Biotechnology, Healthcare, Others), Deployment (On-Cl...
$ 3450
Medical Bionics Comprehensive Study by Type (Ear Bionics, Orthopaedic Bionics, Vision Bionics, Neural /Brain Bionics, Heart Bionics), Application (Implantable, Externally Worn), Technology (Electroni...
$ 3450
Virtual Clinical Trials Comprehensive Study by Application (Oncology, Cardiovascular Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Others), Design (Interventional, Observa...
$ 3800